What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Year 2024 Data d'inici Fri, 6 Sep 2024 - 12:00 Data de tancament Fri, 20 Sep 2024 - 12:00 Descripció Innovation Manager_20240316 Codi 2024-316 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0316//2024_0316_001.pdf Reclutant Inactiu Prevención de la mortalidad con la administración a largo plazo de albúmina humana en sujetos con cirrosis descompensada y ascitis. Contact Protocol code: IG1601 EudraCT code: 2016-001789-28 Principal investigator: Genescà Ferrer, Joan Research group: Malalties hepàtiques Service: Hepatologia Phase: Fase III Recruiting: Open Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 3, aleatorizado y doble ciego para evaluar laeficacia y la seguridad de MK-0616 en comparación con ezetimiba o ácidobempedoico o ezetimiba más ácido bempedoico en adultos con hipercolesterolemia... Contact Protocol code: MK-0616-018 EudraCT code: No aplica Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Rial Lorenzo , Nuria Research group: Malalties infeccioses Service: Medicina Interna Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio abierto, multicéntrico que evalúa los cambios en la tensiónarterial en participantes con narcolepsia en la transición del oxibato con niveles altos desodio a XYWAV Contact Protocol code: JZP258-406-01 EudraCT code: No aplica Pathology: Malalties del sistema respiratori Principal investigator: Romero Santo-Tomas, Odile Research group: Pneumologia Service: Neurofisiologia Phase: Phase III Recruiting: Open Status: Tancat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase IIa, aleatorizado, doble ciego y ocntrolado con placebo para evaluar la eficacia y la seguridad de efinopegdutida (MK-6024) en adultos con cirrosis compensada secundaria a esteatohepatitis asociada a disfunción metabólica. Contact Protocol code: MK-6024-017 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Pericàs Pulido, Juan Manuel Research group: Liver Diseases Service: Hepatology Phase: Fase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A phase IIb, multicentre, randomised, double-blind, placebo controlled, crossover study to evaluate the efficacy and safety of Dirocaftor/Posenacaftor/Nesolicaftor in subjects with cystic fibrosis aged 18 years or older (CHOICES) Contact Protocol code: HIT-CF-001 EudraCT code: _ Pathology: Diseases of the respiratory system Principal investigator: Álvarez Fernandez, Antonio Research group: Pneumology Service: Pneumologia Phase: Phase II Recruiting: Open Status: Close Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Year 2024 Data d'inici Tue, 3 Sep 2024 - 12:00 Data de tancament Mon, 30 Sep 2024 - 12:00 Grup de recerca Neuromuscular and Mitochondrial Pathology Descripció Predoctoral FPI contract_Research group on Neuromuscular and Mitochondrial diseases_20240310 Codi 2024-310 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0310//2024_0310_001.pdf Reclutant Actiu Year 2024 Data d'inici Tue, 3 Sep 2024 - 12:00 Data de tancament Mon, 30 Sep 2024 - 12:00 Grup de recerca Pharmacokinetic Nanoparticles Descripció Predoctoral FPI contract_Nanopartículas Farmacocinéticas_20210312 Codi 2024-312 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0312//2024_0312_001.pdf Reclutant Actiu Year 2024 Data d'inici Tue, 3 Sep 2024 - 12:00 Data de tancament Mon, 30 Sep 2024 - 12:00 Grup de recerca Rheumatology Descripció Scientific Clinical Monitor_Rheumalogy Research Group_20240313 Codi 2024-313 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0313//2024_0313_001.pdf Reclutant Actiu Year 2024 Data d'inici Wed, 4 Sep 2024 - 12:00 Data de tancament Wed, 18 Sep 2024 - 12:00 Grup de recerca Stroke research Descripció Research Engineer (Medical Image & AI)-Stroke Research_20240314 Codi 2024-314 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0314//2024_0314_001.pdf Reclutant Inactiu Professionals Rebeca Martinez Ordinas Professionals Luciana Midaglia Fernandez Professionals Belén Sánchez Fernández I am a Biotechnologist, specialized in Biomedicine. Since mid-2024, I have been developing my PhD, focusing on the immune reconstitution of pediatric patients with inborn errors of immunity after hematopoietic stem cell transplant, in the Infection and Immunity in Pediatric Patients group. Professionals Joaquin Ruiz Altarejos Professionals Olga Galera Román Professionals Arnau Noguera Segura Professionals Victoria Carla Fernández Rodríguez Year 2024 Data d'inici Fri, 30 Aug 2024 - 12:00 Data de tancament Fri, 13 Sep 2024 - 12:00 Grup de recerca Molecular Imaging and Therapy Descripció Postdoc position in Molecular Imaging to develop new radiopharmaceuticals_20240308 Codi 2024-308 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0308//2024_0308_001.pdf Reclutant Inactiu Year 2024 Data d'inici Fri, 30 Aug 2024 - 12:00 Data de tancament Fri, 13 Sep 2024 - 12:00 Grup de recerca Molecular Imaging and Therapy Descripció PhD GRIMM_20240309 Codi 2024-309 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0309//2024_0309_001.pdf Reclutant Inactiu Estudio de fase IIb de búsqueda de dosis aleatorizado, multicéntrico, doble ciego, controlado con placebo, de cuatro grupos paralelos en el que se investigan la eficacia y la seguridad de TIN816 administrado mediante perfusión intravenosa en el tratamiento de pacientes con lesión renal aguda asociada a sepsis (LRA-AS) Contact Protocol code: CTIN816B12202 EudraCT code: No aplica Pathology: Certes malalties infeccioses i parasitàries Principal investigator: Ferrer Roca, Ricard Research group: Shock, disfunció orgànica i ressuscitació Service: UCI (servei de cures intensives) Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Pagination First page « Previous page ‹ … Page 1416 Page 1417 Current page 1418 Page 1419 Page 1420 … Next page › Last page »
Year 2024 Data d'inici Fri, 6 Sep 2024 - 12:00 Data de tancament Fri, 20 Sep 2024 - 12:00 Descripció Innovation Manager_20240316 Codi 2024-316 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0316//2024_0316_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 3 Sep 2024 - 12:00 Data de tancament Mon, 30 Sep 2024 - 12:00 Grup de recerca Neuromuscular and Mitochondrial Pathology Descripció Predoctoral FPI contract_Research group on Neuromuscular and Mitochondrial diseases_20240310 Codi 2024-310 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0310//2024_0310_001.pdf Reclutant Actiu
Year 2024 Data d'inici Tue, 3 Sep 2024 - 12:00 Data de tancament Mon, 30 Sep 2024 - 12:00 Grup de recerca Pharmacokinetic Nanoparticles Descripció Predoctoral FPI contract_Nanopartículas Farmacocinéticas_20210312 Codi 2024-312 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0312//2024_0312_001.pdf Reclutant Actiu
Year 2024 Data d'inici Tue, 3 Sep 2024 - 12:00 Data de tancament Mon, 30 Sep 2024 - 12:00 Grup de recerca Rheumatology Descripció Scientific Clinical Monitor_Rheumalogy Research Group_20240313 Codi 2024-313 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0313//2024_0313_001.pdf Reclutant Actiu
Year 2024 Data d'inici Wed, 4 Sep 2024 - 12:00 Data de tancament Wed, 18 Sep 2024 - 12:00 Grup de recerca Stroke research Descripció Research Engineer (Medical Image & AI)-Stroke Research_20240314 Codi 2024-314 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0314//2024_0314_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Fri, 30 Aug 2024 - 12:00 Data de tancament Fri, 13 Sep 2024 - 12:00 Grup de recerca Molecular Imaging and Therapy Descripció Postdoc position in Molecular Imaging to develop new radiopharmaceuticals_20240308 Codi 2024-308 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0308//2024_0308_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Fri, 30 Aug 2024 - 12:00 Data de tancament Fri, 13 Sep 2024 - 12:00 Grup de recerca Molecular Imaging and Therapy Descripció PhD GRIMM_20240309 Codi 2024-309 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0309//2024_0309_001.pdf Reclutant Inactiu
